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Abstract By the use of the yeast two-hybrid screen we have
identified two proteins that interacted with UCH37: S14, which
is a subunit of PA700 and a novel protein, UIP1 (UCH37
interacting protein 1). The interaction of UCH37 with S14 or
UIP1 was confirmed by in vitro binding assay and in vivo co-
immunoprecipitation analysis. The C-terminal extension of
UCH37 is essential for interaction with S14 or UIP1 as shown
by the yeast two-hybrid assay and the in vitro binding assay.
Furthermore, UIP1 blocked the interaction between UCH37 and
S14 in vitro. ß 2001 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
In eukaryotes, ubiquitin-dependent proteolysis is essential
for selective protein degradation by the 26S proteasome.
The ubiquitin-26S proteasome pathway is involved in many
important cellular processes such as cell cycle regulation, dif-
ferentiation, antigen presentation and the stress response etc.
(reviewed in [1^3]).
The 26S proteasome is the proteolytic complex that de-
grades polyubiquitinated proteins [4]. It consists of two sub-
complexes: the barrel-shaped proteolytic core complex (the
20S proteasome) and the 19S regulatory complex (also known
as PA700). The proteolytic activity of the 20S proteasome is
highly regulated by the PA700 [5]. Recently, Cohen and co-
workers reported a PA700-associated isopeptidase that could
selectively disassemble polyubiquitin chains from the distal
end of poorly ubiquitinated protein conjugates [6,7]. This iso-
peptidase is thought to be involved in ‘editing’ ubiquitinated
substrates according to the length of polyubiquitin chains
rather than the structure of the target proteins themselves.
The nucleotide and amino acid sequences of human ubiquitin
C-terminal hydrolase (UCH)37 were deposited in GenBank by
Cohen and co-workers in 1999 as the PA700-associated iso-
peptidase. UCH37 is a UCH that has a C-terminal extension
of V100 amino acids in length in addition to the N-terminal
UCH domain.
We have identi¢ed a 26S proteasome-associated UCH
(Uch2p) in ¢ssion yeast which contains a C-terminal extension
in addition to its N-terminal UCH domain [8]. Uch2p is ho-
mologous (37% identical) to human UCH37 both at the N-
terminal UCH domain and at the C-terminal extension. Re-
cently the homologue of UCH37 in fruit £y was identi¢ed as a
subunit of the 19S regulatory complex [9]. However, the bio-
logical functions and interacting proteins of this 19S regula-
tory complex-associated UCH remain unclear.
Here, we report the identi¢cation of two proteins, S14 and
UCH37 interacting protein 1 (UIP1), which interact with
UCH37. The proteins were identi¢ed by the use of the yeast
two-hybrid screen.
2. Materials and methods
2.1. Plasmid construction
To construct a bait plasmid, UCH37/pAS2-1 (pU1), for the two-
hybrid screen, a full-length open reading frame (ORF) of human
UCH37 cDNA was ampli¢ed from a HeLa cDNA library and in-
serted into a yeast vector, pAS2-1, which expresses GAL4 DNA bind-
ing domain (DNA-BD) fused to target protein (Clontech). Two trun-
cated UCH37 cDNAs were also inserted separately into pAS2-1 for
further characterisation of positive candidates isolated from the yeast
two-hybrid screen: UCH37vC/pAS2-1 (pU2), in which the C-terminal
extension of UCH37 was deleted, and UCH37vN/pAS2-1 (pU3), in
which the N-terminal UCH domain of UCH37 was deleted. The
schematic diagram of the above plasmids constructed is shown in
Fig. 1A. To generate glutathione-S-transferase (GST)-fused UCH37
and UCH37vC, the cDNAs of the entire ORF of UCH37 and trun-
cated (without the C-terminal extension sequence) UCH37 were in-
serted into pGEX-KG (Pharmacia) to generate two plasmids:
UCH37/pGEX-KG and UCH37vC/pGEX-KG. The entire ORF of
human UCH-L3 was also inserted into pGEX-KG to generate a
plasmid, UCH-L3/pGEX-KG. The cDNA of S14, obtained from
the yeast two-hybrid screen, was also inserted into pGEX-KG. The
5P primer for the S14 cDNA, incorporating a FLAG-tag sequence,
was used to generate the FLAG-S14/pGEX-KG. To generate 6UHis-
tagged UIP1 or 6UHis-tagged NonO, the cDNA of UIP1 or NonO
obtained from the yeast two-hybrid screen was inserted into pQE30
(Qiagen). For mammalian expression, the cDNA of UIP1 was in-
serted into pcDNA3 (Invitrogen). The 5P primer for the UIP1
cDNA, incorporating a FLAG-tag sequence, was used to generate
the FLAG-UIP1/pcDNA3. The full-length ORF of UCH37 and trun-
cated (without the C-terminal extension) UCH37 cDNAs were in-
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serted into pCI-neo (Promega). The 5P primer for the UCH37 and
UCH37vC cDNAs, incorporating a Myc-tag sequence, was used to
generate Myc-UCH37/pCI-neo and Myc-UCH37vC/pCI-neo. All
constructs were veri¢ed by DNA sequencing.
2.2. Yeast two-hybrid system
The yeast two-hybrid screen was performed using the MATCH-
MAKER two-hybrid system (Clontech) according to the manufactur-
er’s instructions. The UCH37/pAS2-1 (pU1) plasmid was transformed
into yeast strain PJ69-2A, and the transformed PJ69-2A cells were
mated with a pre-transformed HeLa cell cDNA library (Clontech)
in yeast strain Y187. Library plasmids from positive yeast clones
were subjected to DNA sequencing. L-Galactosidase activity in each
of the transformants was measured according to the method of Miller
[10].
2.3. Reverse transcription-polymerase chain reaction (RT-PCR)
ampli¢cation of UIP1 gene
1 ng of the ¢rst strand cDNA of multiple human tissues (Clontech)
was used as template for RT-PCR. Human glyceraldehyde-3-phos-
phate dehydrogenase (G3PDH) was used as a control.
2.4. Expression and puri¢cation of GST fusion and 6UHis-tagged
proteins
Expression of the GST, GST-UCH37, GST-UCH37vC, GST-
UCH-L3 or GST-FLAG-S14 fusion protein was induced in Escheri-
chia coli strain DH5K which had been transformed with pGEX-KG,
UCH37/pGEX-KG, UCH37vC/pGEX-KG, UCH-L3/pGEX-KG or
FLAG-S14/pGEX-KG plasmid. Induction was by adding isopropyl-
L-D-thiogalactopyranoside (IPTG) to a ¢nal concentration of 0.1 mM.
Proteins extracted from E. coli were puri¢ed using glutathione-agarose
beads (Sigma) and analysed by SDS^PAGE followed by staining
with Coomassie brilliant blue [11]. 6UHis-tagged UIP1 or 6UHis-
tagged NonO was expressed in E. coli strain M15 which had been
transformed with UIP1/pQE30 or NonO/pQE30. The recombinant
proteins were a⁄nity puri¢ed using Talon nickel resin (Clontech)
[12].
2.5. Removal of GST-tag from GST-FLAG-S14
FLAG-S14 was generated by thrombin-mediated cleavage of GST-
FLAG-S14. The procedure for this cleavage is essentially as described
[11].
2.6. In vitro binding assay
Approximately 10 Wg of GST protein or the fusion derivatives im-
mobilised on glutathione-agarose beads was incubated with 10 Wg of
puri¢ed FLAG-S14 or 6UHis-UIP1 for 2 h at 4‡C in binding bu¡er
(150 mM NaCl, 10 mM Tris pH 8.0, 0.3% Nonidet P-40, 1 mM
dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl £uoride
(PMSF)). The mixtures were then subjected to centrifugation and
the pellets were washed three times with the binding bu¡er. The
bound proteins were separated by 10% SDS^PAGE, electro-trans-
ferred onto nitrocellulose membranes and probed with either M2
monoclonal anti-FLAG antibody (Sigma) or monoclonal anti-
6UHis antibody (Qiagen).
2.7. In vitro competitive binding assay
Approximately 10 Wg of GST-UCH37 immobilised on glutathione-
agarose beads was incubated with 10 Wg of FLAG-S14 or 6UHis-
UIP1 for 2 h at 4‡C in binding bu¡er. Then a various amount of
the third protein (as indicated in Section 3) was added to the above
mixtures and incubated for another 2 h at 4‡C in binding bu¡er. The
proteins bound to the glutathione-agarose beads were centrifuged,
washed and analysed as described above. 10 Wg 6UHis-NonO was
used as a control as indicated in Section 3.
2.8. Co-immunoprecipitation
COS-1 cells were cultured in a high glucose (4500 mg/l) version of
Dulbecco’s modi¢ed Eagle’s media (DMEM) supplemented with 10%
foetal calf serum. The procedures for transfection and co-immunopre-
cipitation analysis are essentially as described [13].
2.9. Immunoblotting
Protein samples were separated by SDS^PAGE and transferred
onto nitrocellulose membranes. The blots were probed with speci¢c
antibodies as indicated above. Goat anti-mouse polyclonal antibody
horseradish peroxidase (HRP) conjugate was used as secondary anti-
body. The membranes were visualised by enhanced chemilumines-
cence (SuperSignal West Pico, Pierce).
3. Results
3.1. Isolation of proteins that interact with UCH37 in a yeast
two-hybrid screen
The yeast two-hybrid screen [14] was used to identify cel-
lular proteins that interact with UCH37. A screen of 3U106
pre-transformed HeLa cell cDNA library transformants
yielded 28 positive colonies that were able to grow in media
without histidine and adenine, and were able to express L-
galactosidase. The plasmids from eight of the 28 positive col-
onies had S14 cDNA inserts. The S14 protein is a subunit of
the 26S proteasome [15]. The eight cDNA inserts are identical
and encode the partial sequence of S14 (from amino acid
number 43 to 257 of the total 257 amino acids of S14) as
indicated in Fig. 1B.
The plasmids from four of the 28 positive colonies con-
tained cDNA inserts derived from a novel gene with identical
length (V1.3 kb) encoding a 358 amino acid protein as shown
in Fig. 1B. We name this novel gene UIP1. The nucleotide
and amino acid sequences of UIP1 were deposited in Gen-
Bank/EMBL under accession number AF267739. The de-
duced amino acid sequence of UIP1 is identical to an ex-
pressed-Xq28STS protein (accession number U82695,
deposited in 2000). This indicates that the UIP1 gene resides
on the Xq28 region of the X chromosome. Computer data-
base searches revealed that UIP1 is a novel gene that shows
Fig. 1. A: The schematic diagram of plasmids constructed for the
yeast two-hybrid assay. The full-length ORF of mouse UCH37
cDNA, a truncated UCH37 cDNA (the UCH domain is deleted) or
another truncated UCH37 cDNA (the C-terminal extension was de-
leted) was inserted into a pAS2-1 vector to generate DNA-BD fu-
sion plasmids: pU1, pU2 and pU3 respectively. B: The schematic
diagram of hybrid AD fusion proteins obtained from the yeast two-
hybrid screen. C: The homologous motif common to S14 and
UIP1. DNA-BD represents the DNA binding domain and AD rep-
resents the activation domain.
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no signi¢cant homology to any known gene. Interestingly, a
short stretch of amino acid sequence in UIP1 exhibits 38%
identity to S14 (Fig. 1C). The plasmids of 14 of 28 positive
colonies contained cDNA inserts encoding NonO, a transcrip-
tional regulator [16].
We transformed the S14 or UIP1 plasmid isolated from the
yeast two-hybrid screen individually into yeast strain Y187.
The Y187 yeast strain harbouring S14/pGAD-GH or UIP1/
pGAD-GH was mated with PJ69-2A strain transformed with
pU1, pU2 or pU3 respectively to test the interaction between
S14 or UIP1 with UCH37, UCH37vC or UCH37vN specif-
ically. The L-galactosidase activity of each of the mating dip-
loid strains was measured and several controls were also set
up. As shown in Table 1, S14 was found to interact with
UCH37, but was not able to interact with the N-terminal
UCH domain or C-terminal extension of UCH37. The results
of the yeast two-hybrid assay indicates that S14 may interact
with UCH37 and that the interaction may be dependent on
both the N-terminal UCH domain and the C-terminal exten-
sion of UCH37. When a similar yeast two-hybrid experiment
was performed using UIP1 and UCH37, UIP1 was found to
interact with UCH37 and its C-terminal extension. However,
UIP1 did not interact with the N-terminal part of UCH37
(the part of UCH37 that includes the UCH catalytic domain).
We suggest that UIP1 may bind the C-terminal extension of
UCH37. Furthermore, it appears that UCH37 binds UIP1
more strongly compared to its binding of S14 as judged by
the L-galactosidase activity.
3.2. Transcripts of the UIP1 gene are present in multiple
human tissues
The transcription of the UIP1 gene in human tissues was
studied by RT-PCR. As shown in Fig. 2, bands with various
brightness of the expected size (V500 bp) were ampli¢ed from
multiple human tissues. This indicates that the UIP1 gene is
expressed in many tissues with varied steady state amounts of
Table 1
L-Galactosidase activity of each of mating diploid cells harbouring
DNA BD and AD fused proteins
DNA BD AD Relative activitya
p53 SV40-L-T 1.00
p53 S14 0.02
p53 UIP1 0.01
UCH37 SV40-L-T 0.03
UCH37 S14 0.18
UCH37 UIP1 0.42
UCH37vC SV40-L-T 0.01
UCH37vC S14 0.03
UCH37vC UIP1 0.33
UCH37vN SV40-L-T 0.01
UCH37vN S14 0.02
UCH37vN UIP1 0.02
aRelative activity was calculated from the speci¢c activity of L-ga-
lactosidase using Miller’s method [10]. The values were calculated
from triplicate samples for each of the diploid cells.
Fig. 2. The transcripts of UIP1 from multiple human tissues.
A: RT-PCR was carried out to study the expression of UIP1 gene
using primers speci¢c for the UIP1 gene. Lanes 1^8 show PCR
products ampli¢ed from the following tissues: 1, spleen; 2, thymus;
3, prostate; 4, testis; 5, ovary; 6, small intestine; 7, colon; 8, pe-
ripheral blood leukocyte. B: RT-PCR was carried out to amplify
human G3PDH gene as a control. DNA size markers are shown on
the left.
Fig. 3. In vitro binding assay. Puri¢ed FLAG-S14 (A) or 6UHis-
UIP1 was incubated with GST (lane 1), GST-UCH37 (lane 2),
GST-UCH37vC (lane 3) or GST-UCH37vN (lane 4) bound gluta-
thione-agarose beads. The bound proteins were washed three times,
separated by SDS^PAGE, electro-transferred onto nitrocellulose
membranes and probed with anti-FLAG antibody (A) or anti-
6UHis antibody (B). The puri¢ed FLAG-S14 (A) or 6UHis-UIP1
(B) was used as a positive control (lane 5). Molecular mass markers
are shown in kDa on the left.
Fig. 4. In vitro competitive binding assay. A: Immobilised GST-
UCH37 was incubated with FLAG-S14 ¢rst, and then 10 Wg of
6UHis-NonO (lane 1) or the following amount of 6UHis-UIP1 was
added: 0 Wg (lane 2), 2 Wg (lane 3), 4 Wg (lane 4), 8 Wg (lane 5) or
16 Wg (lane 6). B: Immobilised GST-UCH37 was incubated with
6UHis-UIP1 ¢rst, and then 10 Wg of 6UHis-NonO (lane 1) or the
following amount of FLAG-S14 was added: 0 Wg (lane 2), 10 Wg
(lane 3), 20 Wg (lane 4), 30 Wg (lane 5) or 40 Wg (lane 6). The bound
proteins were washed three times, separated by SDS^PAGE, electro-
transferred onto nitrocellulose membranes and probed with anti-
FLAG antibody (A) or anti-6UHis antibody (B).
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mRNA. Bands of V1000 bp with approximately equal inten-
sity were ampli¢ed from multiple tissues when G3PDH was
used as a control.
3.3. S14 and UIP1 bind to UCH37 in vitro
We carried out in vitro binding assays to con¢rm that S14
or UIP1 could individually bind UCH37 in vitro under con-
ditions other than that of the yeast two-hybrid system, As
shown in Fig. 3A,B, both the FLAG-S14 and 6UHis-UIP1
bound GST-UCH37 in vitro, but the binding was not evident
when the C-terminal extension of UCH37 was deleted. No
binding was detected between FLAG-S14 or 6UHis-UIP1
with GST or GST-UCH-L3 respectively. These results indi-
cate that S14 and UIP1 could bind UCH37 speci¢cally in
vitro in a C-terminal extension dependent manner.
3.4. UIP1 blocks the interaction between S14 and UCH37
in vitro
As the results of experiments using the yeast two-hybrid
assay showed that the interaction between UIP1 and
UCH37 was much stronger than that between S14 and
UCH37, it was therefore of interest to determine whether
the binding of S14 by UCH37 is a¡ected by the presence of
UIP1 in vitro. As shown in Fig. 4A, the interaction of FLAG-
S14 with GST-UCH37 was inhibited by 6UHis-UIP1 but not
by 6UHis-NonO. Furthermore, the interaction of FLAG-S14
with GST-UCH37 was inhibited by of 6UHis-UIP1 in a con-
centration-dependent manner. Almost no detectable FLAG-
S14 was found bound to GST-UCH37 when the molar ratio
of 6UHis-UIP1:FLAG-S14 was 1:1 (lane 6 of Fig. 4A). How-
ever, FLAG-S14 (even at the 6UHis-UIP1:FLAG-S14 molar
ratio of 1:6) had no signi¢cant e¡ect on the amount of
6UHis-UIP1 bound to GST-UCH37 (lane 6 of Fig. 4B).
This indicates that UCH37 binds UIP1 preferentially and
that the binding of S14 by UCH37 may be blocked by UIP1.
3.5. Co-immunoprecipitation analysis
When using anti-Myc antibody to precipitate the lysates
from COS-1 cells co-transfected with FLAG-UIP1/pcDNA3
and Myc-UCH37/pCI-neo or Myc-UCH37vC/pCI-neo, the
FLAG-UIP1 was found to co-precipitate with Myc-UCH37,
but not with Myc-UCH37vC (Fig. 5A). In addition, the co-
immunoprecipitation of FLAG-UIP1 with Myc-UCH37 was
quantitative and speci¢c (Fig. 5B,C). This ¢nding suggests
that the UIP1 could bind UCH37 via its C-terminal extension
in vivo.
4. Discussion
As the PA700-associated isopeptidase (UCH37) has been
shown to edit polyubiquitinated substrates [6,7], it may play
important roles in regulating protein turnover by the 26S
proteasome. We have shown that the gene (uch2) encoding
the homologue (Uch2p) of UCH37 in ¢ssion yeast is not
essential for cell growth [8]. However, whether UCH37 a¡ects
mammalian cell growth is still unclear. Identi¢cation of mam-
malian proteins that interact with UCH37 would go some way
towards the elucidation of the function of UCH37. By per-
forming the yeast two-hybrid screen using UCH37 as a bait,
we have isolated a few candidates that may interact with
UCH37. One candidate, S14, is a subunit of PA700 [15].
The interaction of UCH37 with S14 was further con¢rmed
by an in vitro binding assay. The ¢nding of the interaction
between S14 and UCH37 may provide insights into the sub-
unit arrangement of PA700, in particular the subunits of
PA700 that associate with UCH37.
We did not do the co-immunoprecipitation analysis of S14
and UCH37. This is because both S14 and UCH37 are sub-
units of PA700, and if one subunit is precipitated, then the
whole complex may be co-precipitated. Thus a positive result
from a co-immunoprecipitation analysis of S14 and UCH37
does not necessarily mean that there is a direct interaction
between them.
Another candidate is a transcriptional regulator, NonO
[16]. However, the interaction of UCH37 with NonO was
not detectable by the in vitro binding assay (data not shown).
Whether UCH37 and NonO interact in vivo remains to be
elucidated. Interestingly, a recently identi¢ed protein, BAP1
which contains a UCH domain, binds BRCA1 (a transcrip-
tional regulator) RING ¢nger domain and enhances BRCA1-
mediated cell growth suppression [17]. The C-terminal exten-
sion of UCH37 exhibits extensive homology with the C-ter-
minal tail of BAP1. It is of interest to know whether UCH37
is also involved in transcriptional regulation.
A novel protein, UIP1, was also isolated by the yeast two-
hybrid screen. The interaction of UCH37 with UIP1 was con-
¢rmed by an in vitro binding assay (Fig. 4) and in vivo co-
immunoprecipitation analysis (Fig. 5). The expression of the
UIP1 gene was detected by Northern blotting originally.
However, the signals for UIP1 transcripts in the Northern
blot were very weak using either radioactive or non-radioac-
tive labelling method. So RT-PCR was carried out to detect
the transcripts of the UIP1 gene. The mRNA of the UIP1
gene was found in many tissues with varied expression level.
The transcripts of the mouse homologue (75% identity) of
Fig. 5. Co-immunoprecipitation of Myc-UCH37 with Flag-UIP1.
Cell lysates from COS-1 cells co-transfected with Flag-UIP1/
pcDNA3 and Myc-UCH37/pCI-neo (lane 1) or Flag-UIP1/pcDNA3
and UCH37vC/pCI-neo-Myc (lane 2) were immunoprecipitated us-
ing anti-Myc antibody. The immunoprecipitates were probed with
anti-Flag antibody (A) to detect co-immunoprecipitated protein(s).
The expression of various constructs in both samples was veri¢ed
by Western blotting of a quarter of the total cell lysates prior to
co-immunoprecipitation using either anti-Flag antibody (B) or anti-
Myc antibody (C).
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UIP1 gene were detected in mouse liver and testis by North-
ern blotting. The expression pattern of the mouse UIP1 gene
is similar to that of mouse UCH37 gene (manuscript in prep-
aration). This indicates that UIP1 and UCH37 may be func-
tionally related.
UIP1 possesses a motif sharing high homology with S14. It
is of interest to know whether this motif binds UCH37. This is
being actively investigated in our laboratory. The interaction
of UIP1 with UCH37 is stronger than that of UCH37 with
S14 as shown by the results of the yeast two-hybrid assay and
the in vitro competitive binding assay. This suggests that
UIP1 may modulate UCH37’s interaction with S14 in the
26S proteasome. The C-terminal extension of UCH37 confers
on the enzyme distinctive features not found in other UCHs,
such as UCH-L1 and UCH-L3 that possess only the UCH
domains but do not have C-terminal extensions. We have
shown that the C-terminal extension of Uch2p mediates the
association of Uch2p (the homologue of UCH37) with the
26S proteasome in Schizosaccharomyces pombe [8]. In the
present study we found that UCH37 interact with UIP1 and
S14 in a C-terminal extension dependent manner, and UIP1
was found to interact with the C-terminal extension of
UCH37 alone by yeast two-hybrid system. We postulate
that UIP1 binds the C-terminal extension of UCH37 prefer-
entially and thus blocks the association of UCH37 with
PA700 in the 26S proteasome.
The biological functions of UCH37 are still unclear. Cohen
and co-workers suggested that one of the major functions of
this isopeptidase may be to rescue poorly ubiquitinated pro-
teins from degradation by disassembling their short polyubi-
quitin chains [6,7]. However, our results from the uch2 null
mutant ¢ssion yeast strain showed that high molecular weight
ubiquitin conjugates accumulated after the disruption of the
uch2 gene (manuscript in preparation). This indicates that
Uch2p may facilitate the turnover of ubiquitinated proteins
by the 26S proteasome, probably by trimming the ubiquiti-
nated proteins so that they can be transported through the
narrow ori¢ce and enter the chamber of the 20S proteasome
where proteolysis occurs. The truncated uch2vC (without the
C-terminal extension nucleotide sequence) strain showed a
phenotype similar to that of the uch2 null mutant strain
(manuscript in preparation). This indicates that the Uch2p
may lose its function if disassociated from the 26S protea-
some, even though the N-terminal UCH domain still pos-
sesses the UCH enzymatic function. UIP1 may modulate the
ubiquitinated protein turnover by blocking the association of
UCH37 with the 26S proteasome. This hypothesis warrants
further investigation.
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